Reply to "Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy"

Affiliations

¹ Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
² Department of Neurology, Duke University, Durham, North Carolina, USA.
³ Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, Florida, USA.
⁴ Department of Radiology, Mayo Clinic, Jacksonville, Florida, USA.
⁵ Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA.
⁶ Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
⁷ Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
⁸ Department of Hematology Oncology, Mayo Clinic, Jacksonville, Florida, USA.
⁹ Department of Pediatrics, Division of Blood and Marrow Transplant, University of Minnesota, Minneapolis, Minnesota, USA.

Comment

Philip W Tipton et al. Mov Disord. 2022 May.

. 2022 May;37(5):1109-1110.

doi: 10.1002/mds.29018.

¹ Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
² Department of Neurology, Duke University, Durham, North Carolina, USA.
³ Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, Florida, USA.
⁴ Department of Radiology, Mayo Clinic, Jacksonville, Florida, USA.
⁵ Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA.
⁶ Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
⁷ Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
⁸ Department of Hematology Oncology, Mayo Clinic, Jacksonville, Florida, USA.
⁹ Department of Pediatrics, Division of Blood and Marrow Transplant, University of Minnesota, Minneapolis, Minnesota, USA.

No abstract available

Keywords: CSF1R-related leukoencephalopathy; genetics; treatment; stem cell transplantation.

Comment on

Treatment of CSF1R-Related Leukoencephalopathy: Breaking New Ground.
Tipton PW, Kenney-Jung D, Rush BK, Middlebrooks EH, Nascene D, Singh B, Holtan S, Ayala E, Broderick DF, Lund T, Wszolek ZK. Tipton PW, et al. Mov Disord. 2021 Dec;36(12):2901-2909. doi: 10.1002/mds.28734. Epub 2021 Jul 30. Mov Disord. 2021. PMID: 34329526
Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy.
Horn MA, Myhre AE, Prescott T, Aasly J, Sundal CH, Gedde-Dahl T. Horn MA, et al. Mov Disord. 2022 May;37(5):1108-1109. doi: 10.1002/mds.29011. Mov Disord. 2022. PMID: 35587623 Free PMC article. No abstract available.

1. Horn MA, Myhre AE, Prescott T, et al. Prophylactic allogeneic hematopoietic stem cell therapy for CSF1R-related leukoencephalopathy. Mov Disord 2022. https://doi.org/10.1002/mds.29018
1. Tipton PW, Kenney-Jung D, Rush BK, et al. Treatment of CSF1R-related leukoencephalopathy: breaking new ground. Mov Disord 2021;36:2901-2909.
1. Sundal C, van Gerpen JA, Nicholson AM, et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology 2012;79(6):566-574.
1. Papapetropoulos S, Pontius A, Finger E, et al. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: review of clinical manifestations as foundations for therapeutic development. Front Neurol 2022;12:788168.
1. Delaney C, Farrell M, Doherty CP, et al. Attenuated CSF-1R signaling drives cerebrovascular pathology. EMBO Mol Med 2021;13(2):e12889.